Created in May 2016, Implicity offers an innovative platform for remote monitoring of patients implanted with connected heart prostheses, like pacemakers and defibrillators.

‍

Founded by Arnaud Rosier, a cardiologist and AI researcher, this service allows remote management of alerts from connected devices from 5 top global manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, and Microport) via a single harmonized platform.

‍

Implicity aims to simplify and optimize the remote monitoring of connected cardiac implants in order to improve the quality of care provided, in particular by using cutting-edge artificial intelligence.